The Need for Speed: Strategies to assess the right QC for SARS-CoV-2 and Infectious Diseases Assays

This webinar is hosted by AACC and sponsored by Thermo Fisher Scientific. The webinar was recorded on December 3, 2020.

Speaker: Nathan a. Ledeboer, PhD, Professor and Vice Chair of Pathology and Medical Director of Microbiology, Molecular Diagnostics, Reference Services, and Laboratory Client Services, Froedtert Hospital and Wisconsin Diagnostic Laboratories
Duration: 1 hour

Overview:

Join expert Nathan Ledeboer, PhD as he discusses challenging SARS-CoV-2 quality control issues and how to solve them in this live webinar.

Dr. Ledeboer will also discuss the roles and benefits of 3rd party quality controls and explain how to identify control material, assayed QC versus non-assayed QC, and how to use QC middleware systems to achieve your lab goals. 

At the end of this webinar, participants will be able to:

  • Identify strategies to overcome challenges in choosing the control material for SARS-CoV-2 Nucleic Acid Tests during a global pandemic
  • Describe how QC middleware systems can help manage daily workloads
  • Summarize QC's role in controlling PCR assays with possible false negative/positive results
  • Summarize QC's role in controlling assays for SARS-CoV-2 assessment

Complete the form below to access the webinar recording.

CE credit not available for this webinar.

Nathan A. Ledeboer, PhD biography

Nathan A. Ledeboer, PhD
Professor and Vice Chair of Pathology and Medical Director of Microbiology, Molecular Diagnostics, Reference Services, and Laboratory Client Services
Froedtert Hospital and Wisconsin Diagnostic Laboratories
Milwaukee, WI

Dr. Ledeboer’s primary responsibility is for the medical and technical oversight of the Clinical Microbiology and Molecular Diagnostics Laboratories. In this role he oversees development and implementation of new assays, oversees and sign out all testing performed in these laboratories, and consults with physician colleagues regarding test results and selection.

Research Interests

  • Development of rapid molecular techniques for detection of infectious diseases
  • Host Response to Infection
  • Combining Digital Imaging and Artificial Intelligence
  • Molecular detection and epidemiology of Respiratory Viruses
  • Antimicrobial resistance

 

Nathan A. Ledeboer, PhD

Nathan A. Ledeboer, PhD
Froedtert Hospital and Wisconsin Diagnostic Laboratories
Milwaukee, WI